The global Neurodiagnostics market is anticipated to grow with a CAGR of around 7% during the forecast period (2019-2026). The major factors driving the global market are rising geriatric population, increasing adoption of novel diagnostic technologies, increasing prevalence of neurological diseases. In addition, increasing Patient Base in developing Economies, innovative product development is acting as the key growth opportunities of the global market. Moreover, there has been increasing prevalence of neurological diseases such as Alzheimer’s disease, migraine, Parkinson’s, epilepsy, stroke, multiple sclerosis, neurodegeneration etc. which has led to increased adoption of Neurodiagnostic technologies for diagnosis and treatment of neurological diseases.